(Q33378306)

English

Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

Athanasios Dimopoulos

object named as

Meletios Athanasios Dimopoulos

8

0 references

George Fountzilas

3

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Theofanis Economopoulos

1

object named as

Theofanis Economopoulos

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Constantinos Tsatalas

4

object named as

Constantinos Tsatalas

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Nikolaos Xiros

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Amanda Psyrri

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Athanasios Anagnostopoulos

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sotirios Papageorgiou

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

68-74

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

The management of follicular lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

The role of mitoxantrone in the treatment of indolent lymphomas.

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

1 reference

https://api.crossref.org/works/10.1080%2F10428190701784714

21 January 2018

Identifiers

10.1080/10428190701784714

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33378306&oldid=1743739554"